BENZOYL PEROXIDE

BENZOYL PEROXIDE was reported 6733 times

BENZOYL PEROXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALLERGENIC DESENSITISATION PROCEDURE 1 0.2000
1 BIOPSY LIP 1 0.1000
2 ACHROMOTRICHIA ACQUIRED 3 0.0612
3 ANGIOTENSIN CONVERTING ENZYME DECREASED 1 0.0588
4 EYEBALL AVULSION 2 0.0513
5 ABORTION INDUCED COMPLETE 1 0.0345
6 ACNE CYSTIC 84 0.0279
7 ACNE FULMINANS 5 0.0255
8 CHEMICAL BURN OF SKIN 60 0.0236
9 SEBORRHOEA 86 0.0234
10 ALBUMIN URINE 1 0.0227
11 DILATED PORES 2 0.0220
12 ACNE PUSTULAR 17 0.0207
13 ACNE 1480 0.0195
14 SKIN IRRITATION 869 0.0190
15 SENSITIVE SKIN 127 0.0172
16 ARCUS LIPOIDES 1 0.0159
17 SKIN FRAGILITY 36 0.0148
18 SKIN BURNING SENSATION 975 0.0136
19 SKIN HYPOPIGMENTATION 24 0.0136
20 AUTOPHONY 1 0.0133
21 SKIN HYPERPIGMENTATION 114 0.0133
22 ACTINIC ELASTOSIS 1 0.0132
23 AMMONIA DECREASED 1 0.0128
24 PAIN OF SKIN 320 0.0119
25 APPLICATION SITE ECZEMA 1 0.0115
26 DRY SKIN 1509 0.0113
27 BASE EXCESS INCREASED 1 0.0112
28 CHEMICAL BURN 12 0.0104
29 SKIN DISCOMFORT 28 0.0104
30 ATYPICAL MYCOBACTERIUM TEST POSITIVE 1 0.0103
31 MEDICAL DIET 2 0.0102
32 SKIN SWELLING 88 0.0101
33 BAND NEUTROPHIL PERCENTAGE INCREASED 1 0.0096
34 SKIN TIGHTNESS 44 0.0093
35 AMIMIA 1 0.0091
36 CHEMICAL INJURY 7 0.0086
37 PILONIDAL DISEASE 2 0.0083
38 APPLICATION SITE PUSTULES 3 0.0082
39 ABDOMINAL WALL MASS 1 0.0082
40 SKIN DISCHARGE 3 0.0079
41 EYELID EXFOLIATION 6 0.0076
42 BASAL GANGLIA STROKE 1 0.0069
43 POLYARTERITIS NODOSA 4 0.0068
44 SKIN EXFOLIATION 562 0.0067
45 AORTIC VALVE THICKENING 1 0.0062
46 APPLICATION SITE OEDEMA 2 0.0062
47 ERYTHEMA 1162 0.0056
48 ENDOMETRIAL ABLATION 2 0.0056
49 PNEUMOMEDIASTINUM 10 0.0055
50 MILIA 2 0.0055
51 RASH PAPULAR 120 0.0053
52 APPLICATION SITE INJURY 1 0.0053
53 ILEITIS 2 0.0052
54 ANAL ULCER 4 0.0049
55 APPLICATION SITE SWELLING 24 0.0048
56 ADULT FAILURE TO THRIVE 1 0.0047
57 SCAR 80 0.0047
58 NECROTISING MYOSITIS 4 0.0046
59 SKIN INJURY 15 0.0045
60 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0045
61 PERINEAL ABSCESS 2 0.0044
62 POST INFLAMMATORY PIGMENTATION CHANGE 2 0.0044
63 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
64 MECHANICAL URTICARIA 2 0.0043
65 SWELLING FACE 269 0.0041
66 COLON ADENOMA 4 0.0041
67 EYE SWELLING 151 0.0041
68 BLADDER DISCOMFORT 5 0.0040
69 APPLICATION SITE WARMTH 5 0.0039
70 APPLICATION SITE PAPULES 4 0.0038
71 LIP ERYTHEMA 3 0.0038
72 PERIORBITAL CELLULITIS 2 0.0037
73 LEFT ATRIAL ENLARGEMENT 2 0.0037
74 ABDOMINAL WOUND DEHISCENCE 1 0.0037
75 DERMATITIS 75 0.0036
76 ENTEROBACTER INFECTION 6 0.0036
77 AVULSION FRACTURE 1 0.0035
78 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
79 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
80 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 624 0.0035
81 BACTERIAL TEST 1 0.0034
82 PROCTITIS ULCERATIVE 2 0.0033
83 ALLERGY TO METALS 2 0.0033
84 APPLICATION SITE DRYNESS 11 0.0032
85 EYELID IRRITATION 8 0.0032
86 PERIORAL DERMATITIS 2 0.0031
87 SKIN TEXTURE ABNORMAL 3 0.0031
88 ASPERGILLOMA 1 0.0031
89 BENIGN NEOPLASM OF SKIN 1 0.0030
90 SKIN WARM 17 0.0029
91 BASAL GANGLIA INFARCTION 1 0.0029
92 ATHEROSCLEROSIS 1 0.0029
93 DERMATITIS CONTACT 33 0.0029
94 APPLICATION SITE INFLAMMATION 4 0.0029
95 ASTHMA EXERCISE INDUCED 1 0.0029
96 SWELLING OF EYELID 18 0.0029
97 BURNS THIRD DEGREE 3 0.0028
98 GASTROINTESTINAL OEDEMA 5 0.0028
99 JUGULAR VEIN THROMBOSIS 5 0.0028
100 UNDERDOSE 199 0.0027
101 SMALL INTESTINAL PERFORATION 5 0.0027
102 SKIN FISSURES 52 0.0027
103 RASH MACULAR 93 0.0027
104 APPLICATION SITE DISCHARGE 3 0.0026
105 ADENOIDECTOMY 1 0.0026
106 PUSTULE 6 0.0025
107 EYELID SKIN DRYNESS 3 0.0025
108 XEROSIS 3 0.0024
109 SEBORRHOEIC DERMATITIS 4 0.0024
110 HIDRADENITIS 22 0.0024
111 PERIORBITAL PAIN 2 0.0024
112 ROSACEA 11 0.0024
113 CYSTOCELE 2 0.0023
114 PERIORBITAL SWELLING 13 0.0023
115 BURNS SECOND DEGREE 4 0.0023
116 OVERDOSE 491 0.0023
117 LARGE INTESTINAL OBSTRUCTION 5 0.0022
118 NEUROPSYCHIATRIC SYMPTOMS 2 0.0022
119 ALLERGY TEST POSITIVE 1 0.0022
120 SCAB 25 0.0022
121 CEREBRAL ISCHAEMIA 11 0.0021
122 SMEAR CERVIX ABNORMAL 3 0.0021
123 SKIN HAEMORRHAGE 31 0.0021
124 BLOOD BICARBONATE INCREASED 1 0.0021
125 PULMONARY VALVE INCOMPETENCE 3 0.0021
126 DERMAL CYST 5 0.0020
127 ERYTHEMA OF EYELID 11 0.0020
128 BLEPHARAL PIGMENTATION 1 0.0020
129 EYELID PAIN 4 0.0020
130 APPLICATION SITE INFECTION 1 0.0020
131 SKIN INFECTION 22 0.0020
132 PHARYNGEAL OEDEMA 30 0.0019
133 APPLICATION SITE EXFOLIATION 8 0.0019
134 MULTIPLE-DRUG RESISTANCE 6 0.0019
135 SKIN DISCOLOURATION 88 0.0019
136 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
137 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
138 SKIN EROSION 6 0.0019
139 SKIN WRINKLING 5 0.0018
140 CATHETER SITE DISCHARGE 2 0.0018
141 SKIN HYPERTROPHY 5 0.0018
142 THROAT TIGHTNESS 48 0.0018
143 HYPERSENSITIVITY 328 0.0018
144 APPLICATION SITE DISCOLOURATION 7 0.0017
145 AORTIC CALCIFICATION 1 0.0017
146 ADENOMYOSIS 1 0.0017
147 NASAL OEDEMA 3 0.0017
148 RASH ERYTHEMATOUS 79 0.0017
149 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
150 DERMATITIS ACNEIFORM 10 0.0016
151 FURUNCLE 13 0.0016
152 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
153 POST-ACUTE COVID-19 SYNDROME 2 0.0016
154 CHAPPED LIPS 7 0.0016
155 ALLERGY TO CHEMICALS 2 0.0016
156 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
157 BACILLUS INFECTION 1 0.0016
158 SKIN REACTION 22 0.0016
159 PAPULE 11 0.0016
160 WISDOM TEETH REMOVAL 2 0.0015
161 HIRSUTISM 2 0.0015
162 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 1 0.0015
163 SKIN MASS 10 0.0015
164 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
165 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
166 SKIN ABRASION 7 0.0015
167 CORNEAL ABRASION 2 0.0015
168 APPLICATION SITE ERYTHEMA 38 0.0014
169 DRUG INEFFECTIVE 1899 0.0014
170 APPLICATION SITE BURN 7 0.0014
171 APPLICATION SITE SCAB 3 0.0014
172 SEBORRHOEIC KERATOSIS 2 0.0014
173 EYELID OEDEMA 16 0.0014
174 ATROPHIC VULVOVAGINITIS 1 0.0014
175 INTENTIONAL UNDERDOSE 10 0.0014
176 DARK CIRCLES UNDER EYES 2 0.0014
177 PRECANCEROUS SKIN LESION 2 0.0014
178 BLISTER RUPTURE 1 0.0013
179 ARTERIAL INJURY 1 0.0013
180 EMBOLISM 11 0.0013
181 APPLICATION SITE PAIN 29 0.0013
182 PRURITUS 504 0.0013
183 PANCREATITIS NECROTISING 3 0.0013
184 LIP SWELLING 43 0.0013
185 POLYCYSTIC OVARIES 2 0.0013
186 EYELIDS PRURITUS 4 0.0013
187 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
188 DERMATITIS ALLERGIC 16 0.0013
189 PULMONARY INFARCTION 3 0.0013
190 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
191 OPTIC NERVE DISORDER 2 0.0012
192 COSTOCHONDRITIS 2 0.0012
193 HYPERPARATHYROIDISM SECONDARY 3 0.0012
194 TONSILLAR HYPERTROPHY 2 0.0012
195 URTICARIA 199 0.0012
196 TYMPANIC MEMBRANE PERFORATION 2 0.0012
197 BLOOD CHLORIDE DECREASED 3 0.0012
198 ACUTE SINUSITIS 2 0.0012
199 TONGUE COATED 2 0.0012
200 CATHETER SITE PAIN 3 0.0012
201 SCRATCH 12 0.0011
202 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
203 ANOGENITAL WARTS 1 0.0011
204 SKIN WEEPING 4 0.0011
205 APPLICATION SITE DISCOMFORT 2 0.0011
206 OBSESSIVE THOUGHTS 2 0.0011
207 LIP DRY 10 0.0011
208 RASH 479 0.0011
209 ABULIA 1 0.0011
210 MACULE 3 0.0011
211 NEPHROGENIC ANAEMIA 5 0.0011
212 APPLICATION SITE VESICLES 7 0.0011
213 PROCTITIS 3 0.0011
214 SACROILIITIS 2 0.0011
215 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
216 RESPIRATORY SYMPTOM 3 0.0011
217 SUBCUTANEOUS ABSCESS 5 0.0010
218 MOUTH SWELLING 6 0.0010
219 VULVOVAGINAL PAIN 5 0.0010
220 BILIARY COLIC 3 0.0010
221 PURULENCE 2 0.0010
222 MULTI-ORGAN DISORDER 2 0.0010
223 SKIN PAPILLOMA 4 0.0010
224 DERMATITIS PSORIASIFORM 2 0.0010
225 PERSONALITY CHANGE 9 0.0010
226 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
227 SKIN INDURATION 2 0.0010
228 BLISTER 54 0.0010
229 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
230 FOLLICULITIS 10 0.0010
231 PHARYNGEAL ERYTHEMA 2 0.0009
232 SUNBURN 7 0.0009
233 CATHETER SITE ERYTHEMA 2 0.0009
234 INFLAMMATORY BOWEL DISEASE 9 0.0009
235 OEDEMA MOUTH 3 0.0009
236 OESOPHAGITIS 10 0.0009
237 CEREBELLAR SYNDROME 2 0.0009
238 CORNEAL DISORDER 2 0.0009
239 FEAR OF DEATH 2 0.0009
240 CYST 11 0.0009
241 CROHN'S DISEASE 6 0.0009
242 INFUSION SITE INFECTION 2 0.0009
243 LOCAL SWELLING 15 0.0009
244 INGROWING NAIL 2 0.0008
245 ENDOMETRIOSIS 4 0.0008
246 RASH VESICULAR 4 0.0008
247 RASH PUSTULAR 6 0.0008
248 NEURODERMATITIS 3 0.0008
249 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 57 0.0008
250 APPLICATION SITE SCAR 1 0.0008
251 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
252 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
253 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
254 TONGUE OEDEMA 3 0.0008
255 LACTOSE INTOLERANCE 2 0.0008
256 APPLICATION SITE EROSION 1 0.0008
257 LIPOMA 2 0.0008
258 ABDOMINAL OPERATION 1 0.0008
259 APPLICATION SITE PARAESTHESIA 1 0.0008
260 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
261 ACROCHORDON 1 0.0008
262 PROTEIN TOTAL INCREASED 2 0.0008
263 CHOLECYSTITIS CHRONIC 5 0.0007
264 WEIGHT BEARING DIFFICULTY 2 0.0007
265 CHEILITIS 4 0.0007
266 APPLICATION SITE HAEMORRHAGE 2 0.0007
267 ACUTE RESPIRATORY FAILURE 14 0.0007
268 APPLICATION SITE RASH 10 0.0007
269 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
270 DYSTONIA 14 0.0007
271 ANAL HAEMORRHAGE 2 0.0007
272 CEREBRAL THROMBOSIS 2 0.0007
273 BREAST CANCER STAGE IV 2 0.0007
274 THERMAL BURN 5 0.0007
275 PURULENT DISCHARGE 3 0.0007
276 MICTURITION URGENCY 8 0.0007
277 SKIN CANCER 15 0.0007
278 SKIN ATROPHY 4 0.0007
279 PNEUMOTHORAX 11 0.0007
280 ANKLE OPERATION 1 0.0007
281 ADHESION 1 0.0007
282 APPLICATION SITE PRURITUS 15 0.0007
283 EYE IRRITATION 38 0.0007
284 PORTAL HYPERTENSION 2 0.0006
285 PIGMENTATION DISORDER 4 0.0006
286 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
287 YELLOW SKIN 3 0.0006
288 BACTERIAL VAGINOSIS 1 0.0006
289 BLOOD CREATININE DECREASED 2 0.0006
290 CONDITION AGGRAVATED 193 0.0006
291 ANGIOEDEMA 28 0.0006
292 ECZEMA 33 0.0006
293 APHAGIA 3 0.0006
294 PRODUCT USE IN UNAPPROVED INDICATION 154 0.0006
295 SKIN ULCER 16 0.0006
296 BURNING SENSATION 43 0.0006
297 PHOTOSENSITIVITY REACTION 10 0.0006
298 ADVERSE REACTION 8 0.0006
299 EOSINOPHIL COUNT INCREASED 5 0.0006
300 POST-TRAUMATIC STRESS DISORDER 4 0.0006
301 POTENTIATING DRUG INTERACTION 2 0.0006
302 LACRIMATION INCREASED 18 0.0006
303 ECONOMIC PROBLEM 9 0.0006
304 OCULAR HYPERAEMIA 28 0.0006
305 NOCTURIA 7 0.0006
306 SWOLLEN TONGUE 18 0.0006
307 CAROTID ARTERY STENOSIS 2 0.0006
308 ANHEDONIA 15 0.0006
309 SENSITIVITY TO WEATHER CHANGE 3 0.0006
310 ALOPECIA AREATA 1 0.0006
311 APPLICATION SITE REACTION 4 0.0006
312 EYE PRURITUS 19 0.0006
313 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
314 ANAL FISTULA 3 0.0006
315 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
316 LUPUS-LIKE SYNDROME 5 0.0006
317 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
318 WOUND HAEMORRHAGE 2 0.0005
319 HYPERACUSIS 2 0.0005
320 FLANK PAIN 5 0.0005
321 BLOOD BICARBONATE DECREASED 1 0.0005
322 HYPERTONIA 3 0.0005
323 IRRITABLE BOWEL SYNDROME 11 0.0005
324 EPIGASTRIC DISCOMFORT 2 0.0005
325 PROCEDURAL HAEMORRHAGE 2 0.0005
326 AFFECTIVE DISORDER 4 0.0005
327 SKIN ODOUR ABNORMAL 2 0.0005
328 ANAPHYLACTIC REACTION 28 0.0005
329 TRICUSPID VALVE INCOMPETENCE 4 0.0005
330 ANORECTAL DISORDER 1 0.0005
331 CANDIDIASIS 2 0.0005
332 ORGAN FAILURE 2 0.0005
333 FUNGAL SKIN INFECTION 2 0.0005
334 ENURESIS 2 0.0005
335 GOITRE 2 0.0005
336 TENDERNESS 5 0.0005
337 RASH PRURITIC 26 0.0005
338 SELF-INJURIOUS IDEATION 2 0.0005
339 SLEEP TERROR 2 0.0005
340 FACE OEDEMA 8 0.0005
341 SKIN PLAQUE 4 0.0005
342 SKIN LESION 13 0.0005
343 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26 0.0005
344 LIP OEDEMA 2 0.0005
345 SLEEP APNOEA SYNDROME 9 0.0005
346 SHOULDER OPERATION 2 0.0005
347 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
348 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
349 SKIN LACERATION 5 0.0005
350 IMMOBILE 2 0.0005
351 MELANOCYTIC NAEVUS 2 0.0005
352 GROIN PAIN 4 0.0005
353 RHINITIS ALLERGIC 2 0.0004
354 FACIAL PAIN 4 0.0004
355 BREAST MASS 3 0.0004
356 REBOUND EFFECT 5 0.0004
357 MITRAL VALVE INCOMPETENCE 5 0.0004
358 VASCULAR DEVICE INFECTION 2 0.0004
359 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
360 DYSPAREUNIA 2 0.0004
361 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
362 LOCALISED OEDEMA 2 0.0004
363 BILIRUBIN CONJUGATED INCREASED 1 0.0004
364 AUTOIMMUNE DISORDER 4 0.0004
365 PRODUCT USE ISSUE 77 0.0004
366 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
367 NIGHTMARE 14 0.0004
368 PHARYNGITIS 5 0.0004
369 INJECTION SITE DISCOLOURATION 5 0.0004
370 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
371 SWELLING 37 0.0004
372 TOOTH ABSCESS 4 0.0004
373 ANGLE CLOSURE GLAUCOMA 1 0.0004
374 DEVICE DISLOCATION 17 0.0004
375 INCREASED UPPER AIRWAY SECRETION 2 0.0004
376 AORTIC ARTERIOSCLEROSIS 1 0.0004
377 VARICOSE VEIN 2 0.0004
378 INTENTIONAL DOSE OMISSION 11 0.0004
379 PERIORBITAL OEDEMA 2 0.0004
380 EYE DISCHARGE 4 0.0004
381 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
382 BLOOD ALBUMIN DECREASED 3 0.0004
383 ABSCESS 6 0.0004
384 ANGIONEUROTIC OEDEMA 1 0.0004
385 FEELING HOT 23 0.0004
386 BRUXISM 2 0.0004
387 ABDOMINAL RIGIDITY 1 0.0004
388 ANORGASMIA 1 0.0004
389 BIPOLAR DISORDER 4 0.0004
390 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
391 IMPAIRED GASTRIC EMPTYING 5 0.0004
392 HYPERAESTHESIA 3 0.0004
393 ASTHENOPIA 2 0.0004
394 SKIN DISORDER 12 0.0004
395 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
396 STREPTOCOCCAL INFECTION 2 0.0004
397 HUNGER 5 0.0004
398 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
399 EYE INFECTION 4 0.0004
400 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
401 GRANULOCYTOPENIA 2 0.0004
402 NEUROLOGICAL SYMPTOM 2 0.0003
403 RASH GENERALISED 9 0.0003
404 MUSCLE STRAIN 3 0.0003
405 PANCREATIC CARCINOMA 10 0.0003
406 HYPERVENTILATION 2 0.0003
407 ADENOVIRUS INFECTION 1 0.0003
408 HYPOVOLAEMIA 2 0.0003
409 SPINAL OSTEOARTHRITIS 3 0.0003
410 SPLENOMEGALY 4 0.0003
411 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
412 PARAESTHESIA 53 0.0003
413 ODYNOPHAGIA 2 0.0003
414 PROTHROMBIN TIME PROLONGED 2 0.0003
415 THERAPY NON-RESPONDER 15 0.0003
416 LOSS OF LIBIDO 3 0.0003
417 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
418 OSTEOPENIA 5 0.0003
419 PANIC ATTACK 12 0.0003
420 RETINAL DETACHMENT 3 0.0003
421 GENERALISED OEDEMA 4 0.0003
422 TENDONITIS 5 0.0003
423 ERYTHEMA MULTIFORME 3 0.0003
424 DEFORMITY 3 0.0003
425 PRE-EXISTING CONDITION IMPROVED 2 0.0003
426 BLOOD BLISTER 1 0.0003
427 NASAL DRYNESS 2 0.0003
428 LACERATION 3 0.0003
429 ARTERIOSCLEROSIS 3 0.0003
430 INFUSION SITE SWELLING 2 0.0003
431 BLEPHAROSPASM 2 0.0003
432 PROCTALGIA 2 0.0003
433 HYPERCHOLESTEROLAEMIA 3 0.0003
434 ATELECTASIS 3 0.0003
435 BREAST CANCER STAGE III 2 0.0003
436 HERPES SIMPLEX 2 0.0003
437 HAEMORRHOIDS 6 0.0003
438 PHARYNGEAL SWELLING 3 0.0003
439 EXPOSURE DURING PREGNANCY 19 0.0003
440 POLYP 2 0.0003
441 GASTRITIS 8 0.0003
442 IMMUNE SYSTEM DISORDER 4 0.0003
443 STAPHYLOCOCCAL INFECTION 10 0.0003
444 ABORTION SPONTANEOUS 12 0.0003
445 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
446 EYELID PTOSIS 3 0.0003
447 MOOD ALTERED 8 0.0003
448 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
449 ONYCHOCLASIS 2 0.0003
450 LYMPHOEDEMA 2 0.0003
451 LARGE INTESTINE POLYP 2 0.0003
452 PRODUCT ODOUR ABNORMAL 3 0.0003
453 WOUND 8 0.0003
454 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
455 INJURY 20 0.0003
456 DERMATITIS ATOPIC 15 0.0003
457 JOINT DISLOCATION 3 0.0003
458 DRUG ERUPTION 5 0.0003
459 THIRST 5 0.0003
460 IMPAIRED QUALITY OF LIFE 4 0.0003
461 APPARENT DEATH 1 0.0003
462 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
463 END STAGE RENAL DISEASE 5 0.0003
464 ANAPHYLACTIC SHOCK 7 0.0003
465 BLINDNESS TRANSIENT 2 0.0003
466 AMYLASE INCREASED 1 0.0003
467 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
468 CEREBRAL DISORDER 2 0.0003
469 NEOPLASM MALIGNANT 18 0.0003
470 HYDRONEPHROSIS 2 0.0003
471 DEPRESSED MOOD 14 0.0003
472 AUTOIMMUNE THYROIDITIS 1 0.0003
473 EAR INFECTION 7 0.0003
474 CHOLECYSTECTOMY 3 0.0003
475 DEEP VEIN THROMBOSIS 17 0.0003
476 INSURANCE ISSUE 4 0.0003
477 LIPASE INCREASED 2 0.0003
478 METASTASES TO LUNG 3 0.0003
479 FOOD ALLERGY 2 0.0003
480 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
481 THERAPY PARTIAL RESPONDER 4 0.0003
482 SEXUAL DYSFUNCTION 3 0.0003
483 DEPRESSION 58 0.0003
484 BACTERAEMIA 3 0.0003
485 NASAL DISCOMFORT 2 0.0003
486 CHOLECYSTITIS 3 0.0003
487 OBESITY 4 0.0003
488 BLEPHARITIS 1 0.0002
489 RHINITIS 2 0.0002
490 MUSCLE DISORDER 2 0.0002
491 SUBSTANCE ABUSE 2 0.0002
492 POLYURIA 2 0.0002
493 DYSPNOEA 138 0.0002
494 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
495 DEVICE MALFUNCTION 17 0.0002
496 SPINAL COMPRESSION FRACTURE 2 0.0002
497 AORTIC DISSECTION 1 0.0002
498 APPLICATION SITE IRRITATION 3 0.0002
499 POLLAKIURIA 10 0.0002
500 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
501 INFUSION SITE ERYTHEMA 2 0.0002
502 AORTIC VALVE INCOMPETENCE 1 0.0002
503 ABSCESS LIMB 1 0.0002
504 MYDRIASIS 3 0.0002
505 ABNORMAL SENSATION IN EYE 1 0.0002
506 PARANOIA 4 0.0002
507 ANXIETY 66 0.0002
508 PSYCHOLOGICAL TRAUMA 2 0.0002
509 HIATUS HERNIA 3 0.0002
510 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
511 NODULE 3 0.0002
512 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
513 DEAFNESS 6 0.0002
514 TREATMENT FAILURE 19 0.0002
515 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
516 NAIL DISORDER 2 0.0002
517 GRIP STRENGTH DECREASED 2 0.0002
518 LYMPHOCYTE COUNT DECREASED 4 0.0002
519 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
520 RESPIRATORY RATE INCREASED 2 0.0002
521 JOINT RANGE OF MOTION DECREASED 3 0.0002
522 ORAL PAIN 5 0.0002
523 DRUG-INDUCED LIVER INJURY 7 0.0002
524 THROAT IRRITATION 10 0.0002
525 HEAVY MENSTRUAL BLEEDING 2 0.0002
526 SINUS CONGESTION 3 0.0002
527 DYSPHAGIA 21 0.0002
528 EXOSTOSIS 2 0.0002
529 NERVE COMPRESSION 2 0.0002
530 CONJUNCTIVITIS 4 0.0002
531 THINKING ABNORMAL 4 0.0002
532 PSORIASIS 28 0.0002
533 CHOLELITHIASIS 7 0.0002
534 EYE PAIN 12 0.0002
535 BLOOD SODIUM DECREASED 4 0.0002
536 SEASONAL ALLERGY 3 0.0002
537 SPUTUM DISCOLOURED 2 0.0002
538 CHRONIC KIDNEY DISEASE 16 0.0002
539 BRONCHOSPASM 3 0.0002
540 RED BLOOD CELL COUNT DECREASED 6 0.0002
541 EYE INFLAMMATION 2 0.0002
542 HYPERSOMNIA 6 0.0002
543 SINUS BRADYCARDIA 2 0.0002
544 APATHY 3 0.0002
545 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
546 HEPATOMEGALY 2 0.0002
547 VITREOUS FLOATERS 2 0.0002
548 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
549 LIGAMENT SPRAIN 2 0.0002
550 HAEMATOCRIT DECREASED 4 0.0002
551 BLOOD PRESSURE ABNORMAL 4 0.0002
552 ANEURYSM 1 0.0002
553 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
554 DRY EYE 10 0.0002
555 BONE LOSS 3 0.0002
556 BLOOD POTASSIUM DECREASED 6 0.0002
557 POOR QUALITY DEVICE USED 2 0.0002
558 EMOTIONAL DISTRESS 24 0.0002
559 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
560 HAEMATEMESIS 5 0.0002
561 PLEURAL EFFUSION 12 0.0002
562 PSORIATIC ARTHROPATHY 8 0.0002
563 DRUG LEVEL DECREASED 2 0.0002
564 AMMONIA INCREASED 1 0.0002
565 HIP ARTHROPLASTY 3 0.0002
566 INITIAL INSOMNIA 2 0.0002
567 EAR DISCOMFORT 2 0.0002
568 OSTEOPOROSIS 8 0.0002
569 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
570 MUSCULOSKELETAL CHEST PAIN 3 0.0002
571 TEMPERATURE INTOLERANCE 2 0.0002
572 SKELETAL INJURY 2 0.0002
573 BASAL CELL CARCINOMA 3 0.0002
574 BONE DENSITY DECREASED 6 0.0002
575 UNINTENDED PREGNANCY 2 0.0002
576 KNEE ARTHROPLASTY 4 0.0002
577 RENAL PAIN 2 0.0002
578 BREAST PAIN 2 0.0002
579 JOINT INJURY 4 0.0002
580 BODY HEIGHT DECREASED 2 0.0002
581 ANAL FISSURE 1 0.0002
582 NIGHT SWEATS 6 0.0002
583 HALLUCINATION 14 0.0002
584 ANAL ABSCESS 1 0.0002
585 BACK INJURY 2 0.0002
586 INTENTIONAL PRODUCT MISUSE 16 0.0002
587 IMPAIRED HEALING 6 0.0002
588 ASPIRATION 2 0.0002
589 THERAPEUTIC RESPONSE DECREASED 11 0.0002
590 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
591 RESPIRATORY DISTRESS 5 0.0002
592 EXPIRED PRODUCT ADMINISTERED 6 0.0002
593 DIVERTICULITIS 5 0.0002
594 NERVE INJURY 2 0.0002
595 AGGRESSION 9 0.0002
596 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
597 COLITIS ULCERATIVE 8 0.0002
598 MALNUTRITION 2 0.0002
599 INTESTINAL PERFORATION 2 0.0002
600 ACUTE PULMONARY OEDEMA 1 0.0002
601 BLOOD CALCIUM DECREASED 2 0.0002
602 ASTHMA 20 0.0002
603 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
604 SUICIDAL IDEATION 16 0.0002
605 INFLAMMATION 9 0.0002
606 NEOPLASM 2 0.0002
607 PALPITATIONS 20 0.0002
608 SPINAL PAIN 2 0.0002
609 SURGERY 10 0.0002
610 WHEEZING 10 0.0002
611 HYPERLIPIDAEMIA 2 0.0002
612 DISTURBANCE IN ATTENTION 9 0.0002
613 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
614 SYNOVITIS 3 0.0002
615 THYROID CANCER 2 0.0002
616 TOOTHACHE 3 0.0002
617 PELVIC PAIN 3 0.0002
618 BURSITIS 2 0.0002
619 FIBROMYALGIA 4 0.0002
620 TREATMENT NONCOMPLIANCE 9 0.0002
621 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
622 MUSCLE SPASTICITY 2 0.0002
623 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
624 SMALL INTESTINAL OBSTRUCTION 2 0.0002
625 TENDON RUPTURE 2 0.0002
626 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
627 HEPATIC STEATOSIS 3 0.0002
628 ILEUS 2 0.0002
629 MENTAL DISORDER 7 0.0002
630 HAIR COLOUR CHANGES 2 0.0002
631 TOOTH EXTRACTION 2 0.0002
632 MIDDLE INSOMNIA 3 0.0002
633 INTESTINAL OBSTRUCTION 6 0.0002
634 FLATULENCE 9 0.0002
635 CYSTITIS 5 0.0002
636 PULMONARY FIBROSIS 3 0.0002
637 POST PROCEDURAL COMPLICATION 3 0.0002
638 ERECTILE DYSFUNCTION 4 0.0002
639 INFUSION SITE PAIN 2 0.0002
640 ERUCTATION 3 0.0002
641 EAR PAIN 3 0.0002
642 ANGINA UNSTABLE 1 0.0002
643 HYPOAESTHESIA 23 0.0002
644 NASAL CONGESTION 9 0.0002
645 KIDNEY INFECTION 3 0.0002
646 NEPHROLITHIASIS 7 0.0002
647 JOINT STIFFNESS 4 0.0002
648 DISABILITY 3 0.0002
649 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
650 SINUS DISORDER 3 0.0002
651 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
652 VISUAL ACUITY REDUCED 5 0.0002
653 BLOOD CHOLESTEROL INCREASED 7 0.0002
654 MALIGNANT MELANOMA 2 0.0001
655 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
656 PRODUCT ADMINISTRATION ERROR 3 0.0001
657 DISCOMFORT 9 0.0001
658 PULMONARY EMBOLISM 14 0.0001
659 LIMB INJURY 4 0.0001
660 SEIZURE 17 0.0001
661 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
662 BODY TEMPERATURE INCREASED 3 0.0001
663 AKATHISIA 2 0.0001
664 GINGIVAL BLEEDING 2 0.0001
665 PRODUCT PREPARATION ERROR 3 0.0001
666 CHEST PAIN 27 0.0001
667 CONTUSION 14 0.0001
668 INFECTION 21 0.0001
669 TOOTH LOSS 3 0.0001
670 NEOPLASM PROGRESSION 5 0.0001
671 ROAD TRAFFIC ACCIDENT 6 0.0001
672 CARPAL TUNNEL SYNDROME 2 0.0001
673 DYSPEPSIA 14 0.0001
674 OSTEOARTHRITIS 6 0.0001
675 LOSS OF CONSCIOUSNESS 18 0.0001
676 OROPHARYNGEAL PAIN 13 0.0001
677 IMPAIRED WORK ABILITY 3 0.0001
678 LIVER FUNCTION TEST INCREASED 3 0.0001
679 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
680 PRURITUS GENERALISED 3 0.0001
681 VISION BLURRED 19 0.0001
682 PRODUCT DISPENSING ERROR 3 0.0001
683 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
684 DYSSTASIA 4 0.0001
685 MUSCULOSKELETAL STIFFNESS 12 0.0001
686 DYSPHONIA 8 0.0001
687 ILLNESS 14 0.0001
688 DYSURIA 5 0.0001
689 CARDIOMYOPATHY 2 0.0001
690 DEHYDRATION 18 0.0001
691 STEVENS-JOHNSON SYNDROME 3 0.0001
692 RESPIRATORY DISORDER 4 0.0001
693 EPISTAXIS 10 0.0001
694 SPEECH DISORDER 7 0.0001
695 HYPOAESTHESIA ORAL 2 0.0001
696 APHASIA 4 0.0001
697 BLOOD COUNT ABNORMAL 2 0.0001
698 COLITIS 5 0.0001
699 TINNITUS 6 0.0001
700 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
701 THYROID DISORDER 2 0.0001
702 MYALGIA 22 0.0001
703 OEDEMA 7 0.0001
704 EJECTION FRACTION DECREASED 2 0.0001
705 COGNITIVE DISORDER 6 0.0001
706 APNOEA 1 0.0001
707 ACUTE MYELOID LEUKAEMIA 2 0.0001
708 NERVOUS SYSTEM DISORDER 4 0.0001
709 SLEEP DISORDER 9 0.0001
710 ARTHRITIS 10 0.0001
711 PAIN 78 0.0001
712 PRODUCT USE COMPLAINT 2 0.0001
713 CHEST DISCOMFORT 13 0.0001
714 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
715 HEAD INJURY 4 0.0001
716 ABNORMAL BEHAVIOUR 5 0.0001
717 HALLUCINATION, AUDITORY 2 0.0001
718 MIGRAINE 12 0.0001
719 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
720 ATRIAL FLUTTER 1 0.0001
721 HYPOTHYROIDISM 4 0.0001
722 BLOOD DISORDER 1 0.0001
723 SENSORY DISTURBANCE 2 0.0001
724 ABDOMINAL DISTENSION 13 0.0001
725 CONSTIPATION 27 0.0001
726 MENTAL IMPAIRMENT 3 0.0001
727 PRESYNCOPE 3 0.0001
728 OEDEMA PERIPHERAL 15 0.0001
729 ASPHYXIA 1 0.0001
730 INJECTION SITE URTICARIA 3 0.0001
731 LIVER INJURY 3 0.0001
732 METASTASES TO BONE 2 0.0001
733 BRONCHITIS 9 0.0001
734 MANIA 2 0.0001
735 HEART RATE INCREASED 12 0.0001
736 VENTRICULAR TACHYCARDIA 2 0.0001
737 ACUTE CORONARY SYNDROME 1 0.0001
738 BACK PAIN 28 0.0001
739 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
740 RENAL FAILURE 16 0.0001
741 ABDOMINAL PAIN 28 0.0001
742 PNEUMONIA ASPIRATION 3 0.0001
743 FUNGAL INFECTION 4 0.0001
744 URINARY RETENTION 4 0.0001
745 ABDOMINAL DISCOMFORT 20 0.0001
746 PERICARDITIS 2 0.0001
747 ABDOMINAL PAIN LOWER 3 0.0001
748 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
749 HAEMOGLOBIN DECREASED 12 0.0001
750 PERIPHERAL SWELLING 18 0.0001
751 IRRITABILITY 7 0.0001
752 INSOMNIA 31 0.0001
753 JOINT SWELLING 14 0.0001
754 DIPLOPIA 3 0.0001
755 AMENORRHOEA 2 0.0001
756 METASTASES TO LIVER 2 0.0001
757 COLD SWEAT 2 0.0001
758 DRUG INTERACTION 18 0.0001
759 LYMPHADENOPATHY 4 0.0001
760 GOUT 2 0.0001
761 ANAL INCONTINENCE 1 0.0001
762 BLOOD BILIRUBIN INCREASED 3 0.0001
763 GASTROENTERITIS VIRAL 2 0.0001
764 PALLOR 3 0.0001
765 CRYING 4 0.0001
766 MEMORY IMPAIRMENT 15 0.0001
767 HYPERHIDROSIS 14 0.0001
768 NECK PAIN 6 0.0001
769 BACTERIAL INFECTION 2 0.0001
770 PHOTOPHOBIA 2 0.0001
771 ABORTION INDUCED 1 0.0001
772 UNEVALUABLE EVENT 8 0.0001
773 MUSCULAR WEAKNESS 12 0.0001
774 PROTEINURIA 2 0.0001
775 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
776 ARTHRALGIA 43 0.0001
777 PRESCRIBED OVERDOSE 2 0.0001
778 INTERSTITIAL LUNG DISEASE 5 0.0001
779 LIVER FUNCTION TEST ABNORMAL 3 0.0001
780 CHOKING 2 0.0001
781 ORAL HERPES 2 0.0001
782 ASCITES 3 0.0001
783 PRODUCT DOSE OMISSION ISSUE 30 0.0001
784 ABDOMINAL PAIN UPPER 21 0.0001
785 ALOPECIA 20 0.0001
786 PSYCHOTIC DISORDER 3 0.0001
787 URINARY INCONTINENCE 3 0.0001
788 CATARACT 6 0.0001
789 GASTROINTESTINAL DISORDER 9 0.0001
790 INTENTIONAL SELF-INJURY 2 0.0001
791 DRY MOUTH 8 0.0001
792 NAUSEA 78 0.0001
793 WEIGHT INCREASED 22 0.0001
794 NEUTROPHIL COUNT DECREASED 4 0.0001
795 MUSCLE SPASMS 18 0.0001
796 THERAPY INTERRUPTED 7 0.0001
797 THERAPY CESSATION 5 0.0001
798 INJECTION SITE WARMTH 2 0.0001
799 INFLUENZA LIKE ILLNESS 8 0.0001
800 LIMB DISCOMFORT 3 0.0001
801 PERITONITIS 2 0.0001
802 FATIGUE 75 0.0001
803 PULMONARY HYPERTENSION 2 0.0001
804 MUSCULOSKELETAL PAIN 5 0.0001
805 PYREXIA 33 0.0001
806 MOOD SWINGS 3 0.0001
807 OFF LABEL USE 82 0.0001
808 POOR QUALITY SLEEP 2 0.0001
809 ACUTE KIDNEY INJURY 14 0.0001
810 INFUSION RELATED REACTION 6 0.0001
811 DECREASED APPETITE 21 0.0001
812 VIRAL INFECTION 3 0.0001
813 TACHYCARDIA 8 0.0001
814 SYNCOPE 9 0.0001
815 RASH MACULO-PAPULAR 2 0.0001
816 SEPSIS 10 0.0001
817 SOMNOLENCE 18 0.0001
818 SNEEZING 2 0.0001
819 ANAEMIA 17 0.0001
820 TYPE 2 DIABETES MELLITUS 3 0.0001
821 PANCREATITIS ACUTE 2 0.0001
822 OXYGEN SATURATION DECREASED 5 0.0001
823 HYPONATRAEMIA 5 0.0001
824 ANGER 3 0.0001
825 FLUSHING 9 0.0001
826 DIARRHOEA 57 0.0001
827 URINARY TRACT INFECTION 15 0.0001
828 SINUSITIS 9 0.0001
829 HAEMATURIA 3 0.0001
830 GASTRIC DISORDER 3 0.0001
831 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
832 HYPOKALAEMIA 4 0.0001
833 WEIGHT DECREASED 24 0.0001
834 RENAL DISORDER 4 0.0001
835 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
836 COUGH 24 0.0001
837 HEADACHE 53 0.0001
838 PRODUCT PRESCRIBING ERROR 2 0.0001
839 MOBILITY DECREASED 6 0.0001
840 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
841 C-REACTIVE PROTEIN INCREASED 3 0.0001
842 STOMATITIS 5 0.0001
843 ADRENAL INSUFFICIENCY 1 0.0001
844 NEURALGIA 2 0.0001
845 DIZZINESS 41 0.0001
846 RESTLESSNESS 3 0.0001
847 CEREBRAL INFARCTION 2 0.0001
848 AGITATION 6 0.0001
849 ABASIA 2 0.0001
850 INFLUENZA 9 0.0001
851 VISUAL IMPAIRMENT 10 0.0001
852 CONFUSIONAL STATE 13 0.0001
853 DYSPNOEA EXERTIONAL 3 0.0001
854 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
855 VOMITING 37 0.0001
856 HEPATITIS 2 0.0001
857 INTENTIONAL OVERDOSE 5 0.0001
858 UNRESPONSIVE TO STIMULI 2 0.0001
859 RHINORRHOEA 5 0.0001
860 PNEUMONIA 25 0.0001
861 EXPOSURE VIA SKIN CONTACT 2 0.0001
862 AMNESIA 5 0.0001
863 RESPIRATORY TRACT INFECTION 2 0.0001
864 NERVOUSNESS 4 0.0001
865 HAEMORRHAGE 8 0.0001
866 SEDATION 2 0.0001
867 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
868 BEDRIDDEN 1 0.0001
869 DISORIENTATION 3 0.0001
870 PANCREATITIS 4 0.0001
871 HYPERTENSION 16 0.0001
872 BLOOD PRESSURE DECREASED 5 0.0001
873 INJECTION SITE BRUISING 6 0.0001
874 INJECTION SITE PRURITUS 5 0.0001
875 DRUG EFFECT DECREASED 4 0.0001
876 RESPIRATORY ARREST 2 0.0001
877 DRUG INTOLERANCE 7 0.0001
878 ABNORMAL DREAMS 2 0.0001
879 MENTAL STATUS CHANGES 2 0.0001
880 HAEMOPTYSIS 2 0.0001
881 APHONIA 1 0.0001
882 DEMENTIA 2 0.0001
883 PAIN IN EXTREMITY 21 0.0001
884 PAIN IN JAW 2 0.0001
885 CONVULSION 4 0.0001
886 PRODUCT SUBSTITUTION ISSUE 4 0.0001
887 ANOSMIA 1 0.0001
888 SEPTIC SHOCK 3 0.0001
889 BONE PAIN 4 0.0001
890 LIVER DISORDER 3 0.0001
891 PULMONARY OEDEMA 3 0.0001
892 PREMATURE BABY 2 0.0001
893 HEPATIC FAILURE 2 0.0001
894 NEUTROPENIA 9 0.0001
895 MALAISE 29 0.0001
896 SUICIDE ATTEMPT 4 0.0001
897 BLOOD PRESSURE INCREASED 10 0.0001
898 ADVERSE EVENT 6 0.0001
899 GYNAECOMASTIA 2 0.0001
900 ANKLE FRACTURE 1 0.0001
901 CARDIAC DISORDER 6 0.0001
902 ASTHENIA 24 0.0001
903 ARRHYTHMIA 3 0.0001
904 PRODUCTIVE COUGH 3 0.0001
905 MULTIPLE SCLEROSIS 3 0.0001
906 INJECTION SITE HAEMORRHAGE 5 0.0001
907 METABOLIC ACIDOSIS 2 0.0001
908 MOVEMENT DISORDER 2 0.0001
909 HYPOGLYCAEMIA 3 0.0001
910 LUNG DISORDER 3 0.0001
911 EYE DISORDER 2 0.0001
912 TREMOR 10 0.0001
913 LEUKOPENIA 3 0.0001
914 GAIT INABILITY 2 0.0001
915 CELLULITIS 3 0.0001
916 RENAL IMPAIRMENT 5 0.0001
917 FLUID RETENTION 3 0.0001
918 PRODUCT QUALITY ISSUE 8 0.0001
919 INJECTION SITE PAIN 18 0.0001
920 HEPATIC ENZYME INCREASED 4 0.0001
921 HOSPITALISATION 9 0.0001
922 DELIRIUM 2 0.0001
923 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
924 FALL 19 0.0001
925 HEART RATE DECREASED 2 0.0001
926 HYPOXIA 2 0.0001
927 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
928 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
929 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
930 RESPIRATORY FAILURE 4 0.0001
931 HYPOTENSION 11 0.0001
932 HAEMATOCHEZIA 3 0.0001
933 NASOPHARYNGITIS 10 0.0001
934 ARTHROPATHY 3 0.0001
935 DYSARTHRIA 2 0.0001
936 HOT FLUSH 4 0.0001
937 NEUROPATHY PERIPHERAL 5 0.0001
938 GAIT DISTURBANCE 10 0.0001
939 HERPES ZOSTER 3 0.0001
940 INJECTION SITE SWELLING 4 0.0001
941 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
942 ATRIAL FIBRILLATION 5 0.0001
943 COVID-19 9 0.0001
944 PLASMA CELL MYELOMA 2 0.0001
945 DRUG DOSE OMISSION BY DEVICE 4 0.0001
946 DISEASE PROGRESSION 6 0.0001
947 DEVICE BREAKAGE 2 0.0000
948 COMPLETED SUICIDE 4 0.0000
949 PLATELET COUNT DECREASED 5 0.0000
950 HYPOACUSIS 2 0.0000
951 BALANCE DISORDER 4 0.0000
952 DEVICE LEAKAGE 2 0.0000
953 PRODUCT DOSE OMISSION 3 0.0000
954 BLOOD CREATININE INCREASED 3 0.0000
955 FEELING ABNORMAL 11 0.0000
956 ADVERSE DRUG REACTION 4 0.0000
957 RHEUMATOID ARTHRITIS 5 0.0000
958 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
959 INJECTION SITE REACTION 3 0.0000
960 DISEASE RECURRENCE 2 0.0000
961 COMA 2 0.0000
962 DYSGEUSIA 3 0.0000
963 AGEUSIA 1 0.0000
964 DIABETES MELLITUS 3 0.0000
965 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
966 CARDIAC ARREST 3 0.0000
967 MEDICATION ERROR 2 0.0000
968 ANGINA PECTORIS 1 0.0000
969 LETHARGY 2 0.0000
970 PRODUCT STORAGE ERROR 3 0.0000
971 DRUG WITHDRAWAL SYNDROME 3 0.0000
972 CHILLS 4 0.0000
973 ILL-DEFINED DISORDER 2 0.0000
974 VERTIGO 2 0.0000
975 DRUG DOSE OMISSION 5 0.0000
976 NO ADVERSE EVENT 5 0.0000
977 ACCIDENTAL OVERDOSE 1 0.0000
978 CARDIAC FAILURE 2 0.0000
979 BLINDNESS 1 0.0000
980 INJECTION SITE ERYTHEMA 3 0.0000
981 MYOCARDIAL INFARCTION 4 0.0000
982 DEVICE ISSUE 2 0.0000
983 BREAST CANCER 2 0.0000
984 BLOOD GLUCOSE INCREASED 4 0.0000
985 THROMBOCYTOPENIA 2 0.0000
986 TOXICITY TO VARIOUS AGENTS 3 0.0000
987 INCORRECT DOSE ADMINISTERED 4 0.0000
988 DEATH 12 0.0000
989 CEREBROVASCULAR ACCIDENT 2 0.0000